Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics.

ABSTRACT: Broad-based cognitive deficits are an enduring and disabling symptom for many patients with severe mental illness, and these impairments are inadequately addressed by current medications. While novel drug targets for schizophrenia and depression have emerged from recent large-scale genome-wide association studies (GWAS) of these psychiatric disorders, GWAS of general cognitive ability can suggest potential targets for nootropic drug repurposing. Here, we (1) meta-analyze results from two recent cognitive GWAS to further enhance power for locus discovery; (2) employ several complementary transcriptomic methods to identify genes in these loci that are credibly associated with cognition; and (3) further annotate the resulting genes using multiple chemoinformatic databases to identify "druggab

SUBMITTER: Lam M 

PROVIDER: S-EPMC8357785 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature